AzTrials
AzTrials

Childhood ObesityNCT06170853

The Effect of Exercise With AR Glasses on Metabolic Parameters and Anthropometric Measurements in Obese Adolescents

A study testing Exercise with augmented reality glasses in people with Childhood Obesity, run by TC Erciyes University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years. Read more about this study

Who is it for?
Ages 10 to 19 years
Conditions the study is for
Childhood Obesity
What is being tested?
Exercise with augmented reality glasses
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Dec 2023to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Those between the ages of 10-19,
  • Having been diagnosed with childhood obesity at least six months ago,
  • Do not have any other chronic disease,
  • No psychiatric diagnosis,
  • No orthopedic problems,
  • Able to read and write
Show all 10Show fewer
  • Can speak Turkish,
  • No mental, physical or neurological disability,
  • Residing in the province where the research will be conducted,
  • Children and children with parental consent to participate in the study will be included in the study.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Erciyes University

    Kayseri, 38039

Other trials in Turkey (Türkiye)

About this study

This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years. The study will be conducted with children diagnosed with obesity between the ages of 10-19 years who are followed up in the Pediatric Endocrinology Outpatient Clinic of Erciyes University Health Application and Research Center Fevzi Mercan-Mustafa Eraslan Children's Hospital. According to the sample calculation, a total of 20 obese children aged 10-19 years (AR exercise group=10 and control group=10) will be included in the sample of the study. The data of the study will be collected using the Descriptive Characteristics Form for Obese Children and Their Families, Serum and Urine Biochemistry Values Form, Anthropometric Measurement Values Form, Augmented Reality Goggles, Body Composition Analyzer, Caliper, Tape Measure and Digital Height and Weight Measurement Device. Ethics committee permission was obtained from "Erciyes University Clinical Research Ethics Committee" and institutional permission was obtained from ERU Health Practice and Research Center Mustafa Eraslan Fevzi Mercan Children's Hospital. Hypothesis tests, correlation and regression analyzes will be applied according to the suitability of the data for normal distribution. As a result of the study, it is expected that exercise application with AR glasses will improve metabolic parameters and anthropometric measurement values in obese children.

Read the detailed description

Obesity, which is one of the major health problems in both developed and developing countries today, is a health problem that occurs with an increase in adipose tissue when energy intake is higher than energy consumption and can cause social, psychological and serious medical problems. If current trends continue, it is reported that 70 million children may be obese and overweight by 2025 and obesity will be a leading health problem. Childhood obesity increases in the first year of life, between 5-6 years of age and during puberty. 1/3 of obese children and 80% of obese adolescents remain obese when they reach adulthood. On the other hand, it is known that 30% of adult obesity cases date back to childhood. It has been reported that obesity affects 10.9-20.0% of all children and adolescents. In a study involving 5206 school-age children (mean age 8.6±1.2 years, 50.2% boys) from seven European countries (Turkey, Bulgaria, Romania, Lithuania, Germany, Italy and the Netherlands), it was reported that the prevalence of obesity in Turkish children was 7.7%, the second highest in Europe after Romania. Obesity in childhood has many medical adverse effects on children. Obesity may cause problems such as rapid growth, early menstruation, increase in blood lipids, increase in heart rate and heart rate volume, fatty liver, impaired sugar metabolism, hypertension, increase in white adipose tissue, increase in serum irisin, myonectin, triglyceride, total cholesterol and leptin levels and decrease in omentin-1 levels. In studies conducted in obese and healthy children, it was found that triglyceride, total cholesterol, irisin, low density lipoprotein (LDL-C) and leptin concentrations were higher in obese children compared to healthy children and omentin-1 levels were lower. Considering that childhood obesity continues into adulthood and brings many problems, the importance of combating obesity in this period is clearly seen. Reducing calorie intake, increasing exercise and providing psychosocial support are very important in the fight against obesity. While exercise constitutes a part of the standard treatment of obesity, it has been reported to be more effective than diet because it increases energy expenditure. In studies conducted in obese children, it was found that planned and long-term moderate exercise increased serum irisin, myonectin, omentin-1 and HDL concentrations and decreased serum leptin, triglyceride, total cholesterol and LDL concentrations. It has also been reported that exercise reduces metabolic and cardiovascular complications and improves body composition, cardiovascular health and mental health. Despite the numerous benefits of exercise, it has been reported that regular exercise habits are low in obese children. It has been reported that obese children cannot exercise regularly due to reasons such as low motivation, parents' inability to spare time to spend time with their children, children who are overwhelmed between courses/courses in the exam marathon with career anxiety, lack of emotional support and inability to give up existing habits. In this direction, exercise that requires continuity in the management of childhood obesity can be made dynamic for obese children by using different approaches. Therefore, it is thought that structured exercise with augmented reality glasses (AR) that can respond to the reactions of the obese child will be more dynamic, improve metabolic and anthropometric values and prevent macrovascular complications that may develop in obese children. This study was planned as a randomized controlled experimental study to determine the effect of exercise with AR glasses on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years.

Being tested
Exercise with augmented reality glasses
Keywords
Childhood Obesity, Adolescent, Metabolic Parameters, Augmented Reality Glasses, Anthropometric Values
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise with augmented reality glassesOther

    Three days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.

Study groups in NCT06170853
Study groupRoleWhat they receive
Augmented reality glasses groupExperimentalThree days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.
Receives: Other: Exercise with augmented reality glasses
Control groupNo interventionNo intervention/application will be made to the children who will be included in the control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in serum leptin levels

    Serum leptin of children with type 1 diabetes before, during, after exercise and during the control session.

    Measured: Change in average serum leptin over 12-week sessions

  2. Change in serum irisin levels

    Serum irisin of children with type 1 diabetes before, during, after exercise and during the control session.

    Measured: Change in average serum irisin over 12-week sessions

  3. Change in body mass index

    Average body mass index values of children with obesity before, during, after exercise and during the control session.

    Measured: Change in average body mass index over 12-week sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2023
  2. Study start1 Dec 2023
  3. Primary completion5 Dec 2024
  4. Study completion1 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06170853
Sponsor's protocol ID
2023/198
Status last verified
May 2026
First submitted
6 Dec 2023
Last updated
18 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise with augmented reality glasses in people with Childhood Obesity, run by TC Erciyes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in serum leptin levels (time frame: Change in average serum leptin over 12-week sessions). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in